Is lanolin alcohol comedogenic?
Short answer
Reported concern: Reported concernThe 1984 rabbit ear assay reports lanolin derivatives among the materials that produced comedones, and lanolin alcohol is recorded here as a reported concern at animal-model evidence level on that basis. The source examined the derivative family rather than taking a reading from lanolin alcohol specifically, so this is a group finding carried to a member of the group. The model is reported to overstate results relative to human testing, and no finished-product conclusion follows from it.
Recorded as Lanolin Alcohol · dataset record lanolin-alcohol · reviewed 2026-08-06
What the evidence actually is
The material was applied to animal skin — in this dataset, a rabbit ear assay. It is a screening model, and the human-assay literature reports that it overreacts to comedogenic materials relative to human testing.
What the sources report
The cited rabbit ear assay reports lanolin derivatives among the materials that produced comedones.
What this does not cover
Reported at the level of lanolin derivatives as a family in an animal model rather than as a verified rating for this exact material in human skin. Animal-model comedogenicity is reported to overstate human results, and finished-product behaviour was not established by this source.
Why people ask about Lanolin alcohol
This one is often met under another name. Lanolin alcohol is declared as wool alcohols or wool wax alcohols on a great many labels, and people who have decided to avoid lanolin discover they have been using it without recognising the term. It is common in ointments, balms and barrier creams, which are exactly the heavy products someone reaches for when skin is compromised — and therefore the products most likely to be blamed when congestion follows.
Where the circulating rating for Lanolin alcohol comes from
As with the other lanolin derivatives, the figure in circulation is a family result distributed to individuals. Fulton's 1984 rabbit ear work names lanolin derivatives collectively; lists then publish per-material numbers the source never measured. The qualifications dropped along the way are the same two: the human-assay methodology literature reports this animal model overreacts to comedogenic materials, and the 2006 human study found finished products built from ingredients previously identified as comedogenic were not necessarily comedogenic. The precision of a per-material figure is not supported by how the underlying observation was made.
Names Lanolin alcohol appears under
Declared as Lanolin Alcohol, and very commonly as Wool Alcohols, wool wax alcohols or lanolin alcohols. Those are the same declaration under different conventions, which is the practical naming problem on this record: someone avoiding lanolin will not necessarily recognise wool alcohols as the same material. Acetylated lanolin is a different declared material with its own record here.
Recognised in this dataset as Lanolin Alcohol, and through the recorded aliases wool alcohols, wool wax alcohols, lanolin alcohols. Matching is exact: there is no fuzzy matching anywhere in this tool, so a name not listed here is reported as unrecognised rather than guessed at.
Questions about lanolin alcohol
Are wool alcohols the same as lanolin alcohol?
Yes, those are the same declaration written under different naming conventions, along with wool wax alcohols. This is worth knowing before reading any ingredient list: someone avoiding lanolin can pass over wool alcohols without recognising it as the material they were looking for.
Was lanolin alcohol itself tested in the cited study?
Not individually. The source reports lanolin derivatives as a family among the materials that produced comedones, so what exists is a group observation rather than a measurement of this material. Recording that distinction is the point of the evidence tier shown alongside it.
Should I avoid it if my skin is very dry?
That is a decision this project cannot make for you, and the evidence here does not settle it. What the record supports is that a comedogenicity concern was reported for the derivative family in an animal model reported to overreact, and that finished-product behaviour was not established by it.
Sources cited on this page
These are the sources attached to this record. Nothing on this page is drawn from anything else.
Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear
Fulton JE Jr, Pay SR, Fulton JE 3rd. Journal of the American Academy of Dermatology, 1984. Peer-reviewed. doi:10.1016/s0190-9622(84)80050-x
Rabbit ear assay. This is the historical origin of most ingredient-level comedogenicity lists in circulation today. The assay is a screening model in animal skin, not a measurement of how a finished cosmetic behaves on a human face. Later work (see src-baek-2016) reports that this model overreacts relative to human testing.
Analysis of comedone, sebum and porphyrin on the face and body for comedogenicity assay
Baek JH, Ahn SM, Choi KM, Jung MK, Shin MK, Koh JS. Skin Research and Technology, 2016. Peer-reviewed. doi:10.1111/srt.12244
Human comedogenicity assay methodology study in 66 volunteers. States that the rabbit ear model can replace human testing for screening purposes but that a number of studies have pointed out its disadvantage of overreacting to comedogenic materials. This is the citation behind every 'animal-model evidence may overstate the result' limitation in this dataset.
A re-evaluation of the comedogenicity concept
Draelos ZD, DiNardo JC. Journal of the American Academy of Dermatology, 2006. Peer-reviewed. doi:10.1016/j.jaad.2005.11.1058
Applied a modification of the Mills and Kligman human assay to finished cosmetic products formulated with ingredients previously identified as comedogenic. Reported that finished products using comedogenic ingredients are not necessarily comedogenic. This is the single most important source in this dataset: it is the direct evidence that an ingredient-level match cannot be converted into a finished-product conclusion.
Record reviewed 2026-08-06 by pore-checker prototype dataset compilation (not clinically reviewed).